SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001567619-21-002413
Filing Date
2021-02-08
Accepted
2021-02-08 12:59:19
Documents
1
Period of Report
2021-02-04

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4211
  Complete submission text file 0001567619-21-002413.txt   5525
Mailing Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553
Business Address 51 CHARLES LINDBERGH BOULEVARD UNIONDALE NY 11553 (415) 655-4899
Angion Biomedica Corp. (Issuer) CIK: 0001601485 (see all company filings)

IRS No.: 113430072 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address
Neylan John F. (Reporting) CIK: 0001640447 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39990 | Film No.: 21600447